Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating... see more

CSE:BRAX - Post Discussion

Braxia Scientific Corp > It's Brand New
View:
Comment by Korcan on Apr 01, 2022 8:40pm
This post has been removed in accordance with Community Policy
Comment by cautiousguy on Apr 01, 2022 11:53pm
Newtkon I can still see your lips moving every time you move your dummies mouth.
Comment by cautiousguy on Apr 01, 2022 11:58pm
Hey Newtcon do you do requests?.  Come on tell me again how this will make the stock price soar and the share price will be a dollar by Christmas.  It's one of your best bits.  I don't need you to repost what has already been widely distributed.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities